A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2

The SARS-CoV-2 pandemic has continued for about three years since emerging in late December 2019, resulting in millions of deaths. Therefore, there is an urgent need to develop a safe and effective vaccine to control SARS-CoV-2. In this study, we developed a bacterium-like particle vaccine that disp...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Rina, Shi, Zhuangzhuang, Li, Entao, Zhu, Menghan, Li, Dongxu, Liu, Xiawei, Sun, Yue, Feng, Na, Wang, Jianzhong, Wang, Tiecheng, Xia, Xianzhu, Sun, Weiyang, Gao, Yuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266888/
https://www.ncbi.nlm.nih.gov/pubmed/37348143
http://dx.doi.org/10.1016/j.virol.2023.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266888/
https://www.ncbi.nlm.nih.gov/pubmed/37348143
http://dx.doi.org/10.1016/j.virol.2023.06.005

Ejemplares similares